Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > KRC Insights - FQ3 Update

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Sep 19, 2024 5:48pm

148 Views

Post# 36232006

RE:RE:RE:KRC Insights - FQ3 Update

Agree, for a while they said it wouldn't be zero and that they were going to get that automated line moving with something, regardless of Ontario. On latest call they said they are selling some, if not identical but similar product, but were not breaking it out. If anyone is going to open house this would be interesting insight to gather.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles